Valeant, Ackman Put $42B Botox Maker On Takeover Hit List
Valeant Pharmaceutical International Inc., one of the most acquisitive life sciences companies in recent years, and activist investor Bill Ackman are attempting to buy Botox maker Allergan Inc., which is valued...To view the full article, register now.
Already a subscriber? Click here to view full article